Abstract
Renal cell cancer is one of the tenth most frequent tumor-dependent causes of death worldwide. In localized stages surgical therapy is the only curative option for the patient. If a renal cell carcinoma is diagnosed in late, i.e. advanced/metastasized stages a drug therapy with targeted agents following tumor burden surgery is nowadays the best option to increase patients progression-free survival. Whenever possible, a partial resection should be perform in regard to decrease rates of longtime renal failure.
Translated title of the contribution | Renal cell cancer. From symptoms to therapy |
---|---|
Original language | German |
Journal | Internistische Praxis |
Volume | 52 |
Issue number | 3 |
Pages (from-to) | 539-545 |
Number of pages | 7 |
ISSN | 0020-9570 |
Publication status | Published - 09.2012 |
Research Areas and Centers
- Research Area: Luebeck Integrated Oncology Network (LION)